BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35894441)

  • 1. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
    Müllerová H; Marshall J; de Nigris E; Varghese P; Pooley N; Embleton N; Nordon C; Marjenberg Z
    Ther Adv Respir Dis; 2022; 16():17534666221113647. PubMed ID: 35894441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.
    Løkke A; Hilberg O; Lange P; Ibsen R; Telg G; Stratelis G; Lykkegaard J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():419-429. PubMed ID: 37034899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
    Swart KMA; Baak BN; Lemmens L; Penning-van Beest FJA; Bengtsson C; Lobier M; Hoti F; Vojinovic D; van Burk L; Rhodes K; Garbe E; Herings RMC; Nordon C; Simons SO
    Respir Res; 2023 Nov; 24(1):293. PubMed ID: 37990197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
    Graul EL; Nordon C; Rhodes K; Marshall J; Menon S; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
    Am J Respir Crit Care Med; 2024 Apr; 209(8):960-972. PubMed ID: 38127850
    [No Abstract]   [Full Text] [Related]  

  • 5. EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.
    Nordon C; Rhodes K; Quint JK; Vogelmeier CF; Simons SO; Hawkins NM; Marshall J; Ouwens M; Garbe E; Müllerová H
    BMJ Open; 2023 Apr; 13(4):e070022. PubMed ID: 37185641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.
    Reilev M; Pottegård A; Lykkegaard J; Søndergaard J; Ingebrigtsen TS; Hallas J
    Respirology; 2019 Dec; 24(12):1183-1190. PubMed ID: 31222861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research.
    Cao C; Wu Y; Xu Z; Lv D; Zhang C; Lai T; Li W; Shen H
    Sci Rep; 2015 Nov; 5():16461. PubMed ID: 26553965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
    Dransfield MT; Criner GJ; Halpin DMG; Han MK; Hartley B; Kalhan R; Lange P; Lipson DA; Martinez FJ; Midwinter D; Singh D; Wise R; Kunisaki KM
    J Am Heart Assoc; 2022 Sep; 11(18):e024350. PubMed ID: 36102236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
    Hawkins NM; Nordon C; Rhodes K; Talukdar M; McMullen S; Ekwaru P; Pham T; Randhawa AK; Sin DD
    Heart; 2024 Apr; 110(10):702-709. PubMed ID: 38182279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.
    Vogelmeier CF; Rhodes K; Garbe E; Abram M; Halbach M; Müllerová H; Kossack N; Timpel P; Kolb N; Nordon C
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38555102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.
    Rothnie KJ; Connell O; Müllerová H; Smeeth L; Pearce N; Douglas I; Quint JK
    Ann Am Thorac Soc; 2018 Aug; 15(8):935-946. PubMed ID: 29723057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
    Daniels K; Lanes S; Tave A; Pollack MF; Mannino DM; Criner G; Neikirk A; Rhodes K; Feigler N; Nordon C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():225-241. PubMed ID: 38259591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study.
    Martinez-Garcia MÁ; Faner R; Oscullo G; la Rosa-Carrillo D; Soler-Cataluña JJ; Ballester M; Muriel A; Agusti A
    Respirology; 2021 Aug; 26(8):776-785. PubMed ID: 34002922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.